Your Privacy Choices
We and our partners use cookies for personalized advertising and content.
You have the right to opt-out of the sale or sharing of your personal information.
Learn more
Keytruda Logo
Keytruda Logo › First Patient Dosed in Clinical Trial of Halozyme Investigational